Insight Molecular Diagnostics (IMDX) Change in Acquisitions & Divestments (2015 - 2017)

Insight Molecular Diagnostics (IMDX) posted Change in Acquisitions & Divestments of $432000.0 for Q2 2017, down 13.94% sequentially from $502000.0 in Q1 2017.

Insight Molecular Diagnostics (IMDX) Change in Acquisitions & Divestments (2015 - 2017) Analysis & Trends

Insight Molecular Diagnostics (IMDX) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $432000.0 in Q2 2017.

  • Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $432000.0 in Q2 2017, while the trailing twelve-month figure through Dec 2017 was $934000.0 (changed N/A YoY) and the FY2023 annual result came in at $367000.0, changed N/A from the prior year.
  • Change in Acquisitions & Divestments fell to $432000.0 in Q2 2017 per IMDX's latest filing, from $502000.0 in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $771000.0 in Q4 2015, with the low at $432000.0 in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Insight Molecular Diagnostics 196.41 Mn 167.48 Mn 15,000.00

Historic Data

Download Data
DateValue
Jun 30, 2017 432,000.00
Jun 30, 2017 432,000.00
Mar 31, 2017 502,000.00
Mar 31, 2017 502,000.00
Dec 31, 2015 771,000.00
Dec 31, 2015 771,000.00